CTRI/2024/05/067754尚未招募2 期
Clinical Evaluation of Siddha Management of Muthu Parpam with Brahmi Nei (internal) and Siriya Bringamalaha Thailam (oil bath) for Alathidu Sanni (Attention Deficit Hyperactivity Disorder) in Children. - NI
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Meets the diagnostic symptoms of (Any of the three or above)
- •1. Lack of concentration 2. Talking incessantly
- •3. Blurting things out 4. Frequent jumping from one task to another 5. Being easily distracted 6. Hyperactivity 7. Trouble sitting still 8. Inability to react to other people’s emotions or feelings.
排除标准
- •1. H/O Seizure disorder
- •2. K/C/O Autistic spectrum disorder
- •3. Auditory and visual processing disorder.
- •4. Neurodegenerative disorder.
- •5. Post encephalitic disorder.
研究者
相似试验
已完成
2 期
START (Siddha Treatment Accelerating Recovery from SARS-CoV-2 Test) trial of Siddha treatment for patients with novel coronavirus infectious disease (COVID-19)ISRCTN13311119Eminentlabs GmbH116
尚未招募
3 期
ayuruvi Nei in the treatment of Varal moolamCTRI/2020/02/023354ational institute of Siddha
已完成
2 期
Clinical evaluation of siddha drug brahmi nei(internal) and mahavilwathy thylam (external) for attention deficit hyperactivity disorder in childreCTRI/2021/08/035465ational institute of siddha20
已完成
2 期
Clinical study of Siddha drug MADHUMEGA KUDINEER (Internal) in the treatment of SINAIPAINEERKATTICTRI/2017/07/008965Self10
招募中
2 期
Evaluation of the Efficacy of Two Siddha Drugs Sindhuvallathy Mezhugu and Kalladaippu Kudineer in patients with Kidney StoneCTRI/2013/07/003801Dr K Rajalakshmi90